Choosing a virology services provider is often framed around tangible transactional capabilities, virus stock inventory, assay panel availability, or specialized techniques. But experienced service teams know that technical execution is only as strong as the quality systems supporting it. Impure lots, incomplete testing packages, or missing documentation can delay regulatory submissions and derail timelines.
When selecting a virology service provider, it is easy to primarily focus on the virus stock or assay capabilities a potential partner has, the tangible elements necessary to execute a part of the larger clinical strategy. But any…
